ArticleScientific reports2017

Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.

Yu-Chen Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.